Josep Maria Ribera, MD, PhD, discusses the current standard treatment protocols for Philadelphia chromosome-positive acute lymphoblastic leukemia and the rationale behind them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback